Sigma Planning Corp
- SEC CIK
- 0001449126
- Latest filing
- Aug 7, 2026
MDNAF holding history
Medicenna Therapeutics Corp. in every 13F filed by Sigma Planning Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MDNAF overviewAll 13F holders of MDNAFFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −634,550−100.0% | Sold out | Holders |
| Q3 2023 | 634,550 | $187.1K | <0.1% | +329,250+107.8% | Added | Holders |
| Q2 2023 | 305,300 | $147.1K | <0.1% | +3,250+1.1% | Added | Holders |
| Q1 2023 | 302,050 | $190.2K | <0.1% | −500−0.2% | Reduced | Holders |
| Q4 2022 | 302,550 | $138.6K | <0.1% | +39,500+15.0% | Added | Holders |
| Q3 2022 | 263,050 | $218.0K | <0.1% | +11,000+4.4% | Added | Holders |
| Q2 2022 | 252,050 | $292.0K | <0.1% | +51,750+25.8% | Added | Holders |
| Q1 2022 | 200,300 | $256.0K | <0.1% | +60,250+43.0% | Added | Holders |
| Q4 2021 | 140,050 | $228.0K | <0.1% | +109,550+359.2% | Added | Holders |
| Q3 2021 | 30,500 | $84.0K | <0.1% | +30,500 | New | Holders |